BB BIOTECH AG

BB BIOTECH AG: Dr. Thomas von Planta, buy

BB Biotech AG publishes its interim report

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates

BB BIOTECH AG: Dr. Thomas von Planta, buy

BB BIOTECH AG: Dr. Thomas von Planta, buy

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share

BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy

BB Biotech AG publishes its 2023 annual report

Investor interest returns – dividend yield remains high for 2024

BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors

BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle

BB Biotech AG publishes its interim report

BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies

BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry

BB Biotech AG publishes its interim report

BB BIOTECH AG: Creating blockbuster drugs using algorithms

BB Biotech AG publishes its interim report

BB BIOTECH AG: Lackluster first quarter for biotech stocks

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share

BB Biotech AG publishes its 2022 annual report

BB Biotech AG closes the 2022 fiscal year with a loss

BB BIOTECH AG: Divergent biotech equity markets mirror value over growth theme in 2022 – Proposed dividend of CHF 2.85

BB BIOTECH AG: Molecular strike force for the immune system

BB Biotech AG publishes its interim report

BB BIOTECH AG: US drug pricing legislation drives biotech business to adapt for further innovation

BB BIOTECH AG: Moderna was just the beginning

BB Biotech AG publishes its interim report

BB BIOTECH AG: First signs of increased M&A activity due to attractive valuations

BB BIOTECH AG: Disruptive technologies are changing an entire industry